##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 112 Download : 86

##plugins.themes.academic_pro.article.main##

Abstract

Studies and discussions about different forms of presentation began to spread COVID-19 and its consequences and effects, including olfactory imbalances such as sleep disturbances, anxiety and depression, activity, and breathing.

Keywords

Covid-19 Nasal disorders Arterial hypertension Diabetes

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dr. Mudhar Hameed Rasheed, Dr. Ali Hussein Ali Saeed, & Dr. Mahmood Sami Wafeeq. (2022). Outcomes of Covid-19 on Nasal Disorders and Assessment of Quality of Life in Post-Covid Patients. Texas Journal of Medical Science, 15, 112–119. https://doi.org/10.62480/tjms.2022.vol15.pp112-119
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. (2020) First cases of coronavirus disease (COVID-19) in Brazil, South America (2 genomes, 3rd March 2020). SARS-CoV-2 coronavirus, Genome Reports.
  2. (2021) WHO Coronavirus Disease (COVID-19) Dashboard. Brazil.
  3. Chen N, Zhou M, Dong X, Qu J, Gong F, et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet 395: 507-513.
  4. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, et al. (2021) More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv 2021.
  5. Davidson TM, Murphy C (1997) Rapid clinical evaluation of anosmia. The alcohol sniff test. Arch Otolaryngol Head Neck Surg 123: 591-594.
  6. Patel SR, Malhotra A, Gao X, Hu FB, Neuman MI, et al. (2012) A prospective study of sleep duration and pneumonia risk in women. Sleep 35: 97-101.
  7. Hartley S, Colas des Francs C, Aussert F, Martinot C, Dagneaux S, et al. (2020) Les effets de confinement SARS-CoV-2 sur le sommeil: Enquête en ligne au cours de la quatrième semaine de confinement. Encéphale 46: S53-S59.
  8. Brito-Marques JM de AM, Franco CMR, Brito-Marques PR de, Martinez SCG, Prado GF do, et al. Impact of COVID-19 pandemic on the sleep quality of medical professionals in Brazil. Arq Neuropsiquiatr 79: 149-155.
  9. Wang C, Song W, Hu X, Yan S, Zhang X, et al. (2021) Depressive, anxiety, and insomnia symptoms between the population in quarantine and general population during the COVID-19 pandemic: A case-controlled study. BMC Psychiatry 21: 99. 4. Brann D., Tsukahara T., Weinreb C., Logan D. W., Datta S.R. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients.
  10. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.
  11. Kam Y. W., Okumura Y., Kido H., Ng L.F., Bruzzone R., Altmeyer R. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
  12. Sungnak W, Huang N, Bécavin C, Berg M, HCA Lung Biological Network. SARS-CoV-2 entry genes are most highly expressed in a nasal goblet and ciliated cells within human airways [published online ahead of print March 13, 2020.
  13. Ziegler C., Allon S. J., Nyquist S.K., Mbano I., Miao V.N., Cao Y. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues.
  14. Dhawale V. S., Amara V.R., Karpe P.A., Malek V., Patel D., Tikoo K. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in a rat asthma model.
  15. Bousquet J, Akdis C, Jutel M, Bachert C, Klimek L, Agache I, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement [published online ahead of print March 31, 2020].
  16. Liotta EM, Batra A, Clark JR, et al. Frequent neurological manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann Clin Transl Neurol. 2020;7 (11):2221–2230.
  17. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382 (23):2268–2270.
  18. Garcez FB, Aliberti MJR, Poco PCE, et al. Delirium and adverse outcomes in hospitalized patients with COVID-19. J Am Geriatr Soc. 2020;68 (11):2440–2446.
  19. Abdo WF, Broerse CI, Grady BP, et al. Prolonged unconsciousness following severe COVID-19. Neurology. 2021;96 (10): e1437–e1442.
  20. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94:55–58.